Stay updated on Reslizumab in EGPA: Clinical Trial

Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reslizumab in EGPA: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page’s display revision/version label was updated from v3.5.2 to v3.5.3, indicating a site software update without changing the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-26T15:23:51.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Results have been submitted, replacing the previous 'No Results Posted' status. The page revision has been updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T13:37:53.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0; no changes to the study details or core functionality are observed.
    Difference
    0.1%
    Check dated 2026-03-21T19:55:53.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T06:13:22.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. This is a minor metadata change and does not affect study content or results.
    Difference
    0.1%
    Check dated 2026-02-13T13:53:37.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The only change is a version update from v3.4.0 to v3.4.1; no study content, eligibility criteria, or results were affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:21:10.000Z thumbnail image

Stay in the know with updates to Reslizumab in EGPA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.